Methylphenidate increases glucose uptake in the brain of young and adult rats

BackgroundMethylphenidate (MPH) is the drug of choice for pharmacological treatment of attention deficit hyperactivity disorder. Studies have pointed to the role of glucose and lactate as well as in the action mechanisms of drugs used to treat these neuropsychiatric diseases. Thus, this study aims to evaluate the effects of MPH administration on lactate release and glucose uptake in the brains of young and adult rats.MethodsMPH (1.0, 2.0 and 10.0 mg/kg) or saline was injected in young and adult Wistar male rats either acutely (once) or chronically (once daily for 28 days). Then, the levels of lactate release and glucose uptake were assessed in the prefrontal cortex, hippocampus, striatum, cerebellum and cerebral cortex.ResultsChronic MPH treatment increased glucose uptake at the dose of 10.0 mg/kg in the prefrontal cortex and striatum, and at the dose of 2.0 mg/kg in the cerebral cortex of young rats. In adult rats, an increase in glucose uptake was observed after acute administration of MPH at the dose of 10.0 mg/kg in the prefrontal cortex. After chronic treatment, there was an increase in glucose uptake with MPH doses of 2.0 and 10.0 mg/kg in the prefrontal cortex, and at an MPH dose of 2.0 mg/kg in the striatum of adult rats. The lactate release did not change with either acute or chronic treatments in young or adult rats.ConclusionsThese findings indicate that MPH increases glucose consumption in the brain, and that these changes are dependent on age and posology.